Should tear dysfunction be treated with nutritional supplements?
May 1st 2008Nutritional supplements seem to make sense as a treatment of tear dysfunction, according to Marian Macsai, MD. Dr Macsai tempered her assertion with the observation that no objective trials have been performed to support the use of nutritional supplements in patients with tear deficiency.
Spectral-domain optical coherence tomography represents step forward
April 30th 2008Spectral domain, three-dimensional (3-D), high-resolution optical coherence tomography (OCT) represents a step forward in OCT technology, with precise registration, complete data set acquisition, and improved coverage of the retina being the major advantages.
Breakthrough in understanding vascular biology may lead to safer and more effective anti-angiogenics
April 30th 2008VEGFb, a novel form of vascular endothelial growth factor (VEGF), an anti-angiogenic which is cytoprotective for retinal cells, can inhibit choroidal neovascularization significantly, according to preclinical results presented at this year's BIO National Venture Conference, held April 22?23 in Cambridge, US.
FDA approves expansion of NeoVista's Phase III CABERNET trial
April 23rd 2008The FDA has approved an expansion of the Phase III CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) trial, which is evaluating the safety and efficacy of NeoVista's epiretinal brachytherapy in wet age-related macular degeneration (AMD).
Arsenal of strategies enables safe surgery in IFIS eyes
April 21st 2008Cases of intraoperative floppy iris syndrome (IFIS) encompass a wide spectrum of severity, so it is important for surgeons to master several different strategies to increase the likelihood of achieving a safe outcome in these eyes.
Eye drop contamination comes from bottle, not solution
April 18th 2008Bottles of infected eye drops are more likely to be contaminated with bacteria at the bottle tip and not within the solution, according to a study presented at this year's American Society of Cataract and Refractive Surgery (ASCRS) meeting.
Update and clinical pearls from the TVT study
April 18th 2008The Tube versus Trabeculectomy (TVT) Study found that nonvalved tube shunt surgery was more likely to maintain IOP control and avoid persistent hypotony and reoperation for glaucoma than trabeculectomy with mitomycin C (MMC) during the first year of follow-up.
Human embryonic stem cells have potential to treat retinal degeneration
April 16th 2008Regeneration of damaged retinal cells with the aid of stem cells may offer hope for the treatment of retinal degeneration conditions, such as age-related macular degeneration (AMD) and diabetic retinopathy (DR), according to a report published by the National Academy of Sciences (Volume 103).
Post-LASIK quality of life to be officially assessed
April 14th 2008A new study assessing the quality of life after LASIK is to be conducted by the American Society of Cataract and Refractive Surgery (ASCRS), the American Academy of Ophthalmology, the FDA and the National Eye Institute, it was announced at this year's ASCRS meeting in Chicago, US.